Skip to main content
. 2017 Jun 26;30(5):542–549. doi: 10.20524/aog.2017.0170

Table 2.

Possible priorities for interferon (IFN)-free regimens among the study population (N=500)

graphic file with name AnnGastroenterol-30-542-g002.jpg